Stay updated on Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page.

Latest updates to the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedExpanded study locations across the US (California, Massachusetts, Ohio, Tennessee), Australia (New South Wales, Queensland, Victoria, Western Australia), Canada (Alberta, Ontario, Quebec), and other regions. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPublications section now states entries are automatically populated from PubMed and may not pertain to the study. Revision: version updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding operating-status notice banner was removed from the page.SummaryDifference0.3%

- Check62 days agoChange DetectedNo significant changes detected to the study details or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check91 days agoChange Detected- Added a government funding notice and current operating status information with links; updated version to v3.2.0. - Removed the Huntington disease resource and the previous version tag v3.1.0.SummaryDifference4%

- Check98 days agoChange DetectedCore content updates with a new version (v3.1.0) and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older version (v3.0.2).SummaryDifference0.4%

Stay in the know with updates to Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page.